![Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World Conditions | Journal of Aerosol Medicine and Pulmonary Drug Delivery Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World Conditions | Journal of Aerosol Medicine and Pulmonary Drug Delivery](https://www.liebertpub.com/cms/10.1089/jamp.2015.1216/asset/images/medium/figure1.gif)
Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World Conditions | Journal of Aerosol Medicine and Pulmonary Drug Delivery
![Teva recibe la autorización de comercialización en la UE para Seffalair Spiromax y BroPair Spiromax para el tratamiento del asma Teva recibe la autorización de comercialización en la UE para Seffalair Spiromax y BroPair Spiromax para el tratamiento del asma](http://www.pmfarma.com/noticias/noticias/31216/image/seffalair%20spiromax%20teva.jpg)
Teva recibe la autorización de comercialización en la UE para Seffalair Spiromax y BroPair Spiromax para el tratamiento del asma
![Info Medicamentos on Twitter: "Duoresp Spiromax 160/4.5 Mcg https://t.co/uOg3UbvLob #prospecto #medicamento #salud https://t.co/R4RoNM4hi3" / Twitter Info Medicamentos on Twitter: "Duoresp Spiromax 160/4.5 Mcg https://t.co/uOg3UbvLob #prospecto #medicamento #salud https://t.co/R4RoNM4hi3" / Twitter](https://pbs.twimg.com/media/DL1KXAcWkAAUGsT.jpg)
Info Medicamentos on Twitter: "Duoresp Spiromax 160/4.5 Mcg https://t.co/uOg3UbvLob #prospecto #medicamento #salud https://t.co/R4RoNM4hi3" / Twitter
![Teva receives EU Marketing Authorisation for Seffalair® Spiromax® and BroPair® Spiromax® (salmeterol xinafoate / fluticasone propionate) | Business Wire Teva receives EU Marketing Authorisation for Seffalair® Spiromax® and BroPair® Spiromax® (salmeterol xinafoate / fluticasone propionate) | Business Wire](https://mms.businesswire.com/media/20210408005322/en/739014/23/teva_RGB_JPEG.jpg)